Skip to main content
Premium Trial:

Request an Annual Quote

NIH Sets Aside $574M to Expand Translational Research Consortium

NEW YORK (GenomeWeb News) — The National Institutes of Health has set aside $574 million to expand a national consortium that aims to transform “how clinical and translational research is conducted” by adding a dozen new institutions to the program, the NIH said yesterday.
 
The Clinical Translational Science Awards consortium will use the cash to fuel translational research aimed at creating greater sharing between institutions and disciplines, including genomics.
 
The NIH said the funding will go to 12 institutions beyond the dozen it funded last year, and that by 2012 it will involve 60 institutions. Each institution has a number of centers, labs, schools, and facilities that are or will be involved in the projects.  
 
"Through collaboration and leadership, these sites are serving as discovery engines that can rapidly translate research into prevention strategies and clinical treatments for the people who need them,” NIH Director Elias Zerhouni said in a statement. 
 
The CTSA consortium “also represents our investment in the future as it prepares the next generation of clinical researchers to meet tomorrow's health care challenges," the director added.
 
As GenomeWeb Daily News reported in October 2006 when the consortium began with $100 million in funding, the NIH said the institutions involved will “assemble interdisciplinary teams that cover the complete spectrum of research, [including] biology, clinical medicine, dentistry, nursing, biomedical engineering, genomics, and population sciences; develop better designs for clinical trials to ensure that patients with rare as well as common diseases benefit from new medical therapies; produce enriched environments to educate and develop the next generation of researchers trained in the complexities of translating research discoveries into clinical trials and ultimately into practice; design new and improved clinical research informatics tools; expand outreach efforts to minority and medically underserved communities; [and] forge new partnerships with private and public health care organizations.”
 
Yesterday the NIH did not specify the amount of the awards to specific institutions, but said the following will receive funds under the program: Case Western Reserve University; Emory University; Morehouse School of Medicine; Johns Hopkins University; University of Chicago; University of Iowa; University of Michigan; University of Texas Southwestern Medical Center; University of Washington; University of Wisconsin; Vanderbilt University; Meharry Medical College; Washington University; Weill Cornell Medical College; and Hunter College.
 
More information about the CTSA consortium can be found here.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.